Production of novel diagnostic radionuclides in small medical cyclotrons

The global network of cyclotrons has expanded rapidly over the last decade. The bulk of its industrial potential is composed of small medical cyclotrons with a proton energy below 20 MeV for radionuclides production. This review focuses on the recent developments of novel medical radionuclides produ...

Full description

Saved in:
Bibliographic Details
Published in:EJNMMI radiopharmacy and chemistry 2018-02, Vol.3 (1), p.3-3, Article 3
Main Authors: Synowiecki, Mateusz Adam, Perk, Lars Rutger, Nijsen, J. Frank W.
Format: Article
Language:English
Subjects:
Copper-64
Cyclotron
Imaging
Medicine
Medicine & Public Health
Molecular Medicine
Nuclear Chemistry
Nuclear Medicine
Pharmacotherapy
Radioiodine
Radioisotopes
Radiology
Radionuclide production
Review
Technetium-99 m
Zirconium-89
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The global network of cyclotrons has expanded rapidly over the last decade. The bulk of its industrial potential is composed of small medical cyclotrons with a proton energy below 20 MeV for radionuclides production. This review focuses on the recent developments of novel medical radionuclides produced by cyclotrons in the energy range of 3 MeV to 20 MeV. The production of the following medical radionuclides will be described based on available literature sources: Tc-99 m, I-123, I-124, Zr-89, Cu-64, Ga-67, Ga-68, In-111, Y-86 and Sc-44. Remarkable developments in the production process have been observed in only some cases. More research is needed to make novel radionuclide cyclotron production available for the medical industry.
ISSN:2365-421X
2365-421X
DOI:10.1186/s41181-018-0038-z